For Li-Fraumeni syndrome patients who carry heterozygous germline p53 mutations, patients carrying p53 missense mutations have an earlier cancer onset compared with patients carrying p53 deletion mutations (Bougeard et al., 2008). The gene discussed is TP53; the disease is cancer.